1 - 25 of 153 results for author:"Easton D.F." in Literature citations
Results Customize
› Repeat search in UniProtKB (470)
| Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2. Kirchhoff T., Gaudet M.M., Antoniou A.C., McGuffog L., Humphreys M.K., Dunning A.M., Bojesen S.E., Nordestgaard B.G., Flyger H., Kang D. et al. PLoS ONE 7:e35706-e35706(2012) · Mapped (18) |
| Genome-wide association study of circulating estradiol, testosterone, and sex hormone-binding globulin in postmenopausal women. Prescott J., Thompson D.J., Kraft P., Chanock S.J., Audley T., Brown J., Leyland J., Folkerd E., Doody D., Hankinson S.E. et al. PLoS ONE 7:e37815-e37815(2012) · Mapped (8) |
| Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study. CIMBA, the Consortium of Investigators of Modifiers of BRCA1/2-Related Cancer Br. J. Cancer 106:2016-2024(2012) · Mapped (13) |
| Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk. Vachon C.M., Scott C.G., Fasching P.A., Hall P., Tamimi R.M., Li J., Stone J., Apicella C., Odefrey F., Gierach G.L. et al. Cancer Epidemiol. Biomarkers Prev. 21:1156-1166(2012) · Mapped (8) |
| Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. Consortium of Investigators of Modifiers of BRCA1/2 Cancer Epidemiol. Biomarkers Prev. 21:645-657(2012) · Mapped (4) |
| Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. Bolton K.L., Chenevix-Trench G., Goh C., Sadetzki S., Ramus S.J., Karlan B.Y., Lambrechts D., Despierre E., Barrowdale D., McGuffog L. et al. JAMA 307:382-390(2012) · Mapped (18) |
| The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers. Laitman Y., Kuchenbaecker K.B., Rantala J., Hogervorst F., Peock S., Godwin A.K., Arason A., Kirchhoff T., Offit K., Isaacs C. et al. Breast Cancer Res. Treat. 132:1119-1126(2012) · Mapped (18) |
| Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). Consortium of Investigators of Modifiers of BRCA1/2 Cancer Epidemiol. Biomarkers Prev. 21:134-147(2012) · Mapped (18) |
| Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. Maxwell C.A., Benitez J., Gomez-Baldo L., Osorio A., Bonifaci N., Fernandez-Ramires R., Costes S.V., Guino E., Chen H., Evans G.J. et al. PLoS Biol. 9:e1001199-e1001199(2011) · Mapped (6) |
| A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Yokoyama S., Woods S.L., Boyle G.M., Aoude L.G., MacGregor S., Zismann V., Gartside M., Cust A.E., Haq R., Harland M. et al. |
| Gene-gene interactions in breast cancer susceptibility. Turnbull C., Seal S., Renwick A., Warren-Perry M., Hughes D., Elliott A., Pernet D., Peock S., Adlard J.W., Barwell J. et al. Hum. Mol. Genet. 21:958-962(2012) · Mapped (27) |
| Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2. Mulligan A.M., Couch F.J., Barrowdale D., Domchek S.M., Eccles D., Nevanlinna H., Ramus S.J., Robson M., Sherman M., Spurdle A.B. et al. Breast Cancer Res. 13:R110-R110(2011) · Mapped (18) |
| Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk. Stevens K.N., Garcia-Closas M., Fredericksen Z., Kosel M., Pankratz V.S., Hopper J.L., Dite G.S., Apicella C., Southey M.C., Schmidt M.K. et al. Br. J. Cancer 105:1934-1939(2011) · Mapped (7) |
| Modification of BRCA1-associated breast and ovarian cancer risk by BRCA1-interacting genes. Rebbeck T.R., Mitra N., Domchek S.M., Wan F., Friebel T.M., Tran T.V., Singer C.F., Tea M.K., Blum J.L., Tung N. et al. Cancer Res. 71:5792-5805(2011) · UniProtKB (1) |
| CHEK2, MGMT, SULT1E1 and SULT1A1 polymorphisms and endometrial cancer risk. O'Mara T.A., Ferguson K., Fahey P., Marquart L., Yang H.P., Lissowska J., Chanock S., Garcia-Closas M., Thompson D.J., Healey C.S. et al. Twin Res Hum Genet 14:328-332(2011) · Mapped (9) |
| A role for XRCC2 gene polymorphisms in breast cancer risk and survival. Lin W.Y., Camp N.J., Cannon-Albright L.A., Allen-Brady K., Balasubramanian S., Reed M.W., Hopper J.L., Apicella C., Giles G.G., Southey M.C. et al. J. Med. Genet. 48:477-484(2011) · Mapped (2) |
| Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers. Im K.M., Kirchhoff T., Wang X., Green T., Chow C.Y., Vijai J., Korn J., Gaudet M.M., Fredericksen Z., Shane Pankratz V. et al. Hum. Genet. 130:685-699(2011) · Mapped (18) |
| Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. Antoniou A.C., Kartsonaki C., Sinilnikova O.M., Soucy P., McGuffog L., Healey S., Lee A., Peterlongo P., Manoukian S., Peissel B. et al. Hum. Mol. Genet. 20:3304-3321(2011) · Mapped (18) |
| TGF-beta signaling pathway and breast cancer susceptibility. Scollen S., Luccarini C., Baynes C., Driver K., Humphreys M.K., Garcia-Closas M., Figueroa J., Lissowska J., Pharoah P.D., Easton D.F. et al. Cancer Epidemiol. Biomarkers Prev. 20:1112-1119(2011) · Mapped (9) |
| Exploring the link between MORF4L1 and risk of breast cancer. Martrat G., Maxwell C.M., Tominaga E., Porta-de-la-Riva M., Bonifaci N., Gomez-Baldo L., Bogliolo M., Lazaro C., Blanco I., Brunet J. et al. Breast Cancer Res. 13:R40-R40(2011) · Mapped (5) |
| Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2. Osorio A., Milne R.L., Alonso R., Pita G., Peterlongo P., Teule A., Nathanson K.L., Domchek S.M., Rebbeck T., Lasa A. et al. Br. J. Cancer 104:1356-1361(2011) · Mapped (23) |
| Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers. Spurdle A.B., Marquart L., McGuffog L., Healey S., Sinilnikova O., Wan F., Chen X., Beesley J., Singer C.F., Dressler A.C. et al. Cancer Epidemiol. Biomarkers Prev. 20:1032-1038(2011) · Mapped (13) |
| Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Antoniou A.C., Beesley J., McGuffog L., Sinilnikova O.M., Healey S., Neuhausen S.L., Ding Y.C., Rebbeck T.R., Weitzel J.N., Lynch H.T. et al. Cancer Res. 70:9742-9754(2010) · Mapped (18) |
| Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers. Walker L.C., Fredericksen Z.S., Wang X., Tarrell R., Pankratz V.S., Lindor N.M., Beesley J., Healey S., Chen X., Stoppa-Lyonnet D. et al. Breast Cancer Res. 12:R102-R102(2010) · Mapped (6) |
| Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. Gaudet M.M., Kirchhoff T., Green T., Vijai J., Korn J.M., Guiducci C., Segre A.V., McGee K., McGuffog L., Kartsonaki C. et al. PLoS Genet. 6:e1001183-e1001183(2010) · Mapped (18) |